Financhill
Back

Editas Medicine Vs. Regeneron Pharmaceuticals Industry Stock Comparison

Sell
38

EDIT
Editas Medicine

Last Price:
3.39
Seasonality Move:
22%
Buy
52

REGN
Regeneron Pharmaceuticals

Last Price:
1,012.36
Seasonality Move:
9.32%
Sell
38
Editas Medicine (EDIT) is a Sell

Is Editas Medicine a Buy, Sell or Hold?

  • The current Editas Medicine [EDIT] share price is $3.38. The Score for EDIT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • EDIT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Regeneron Pharmaceuticals (REGN) is a Buy

Is Regeneron Pharmaceuticals a Buy, Sell or Hold?

  • The current Regeneron Pharmaceuticals [REGN] share price is $1,012.82. The Score for REGN is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • REGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

EDIT Stock Price Chart

What is Editas Medicine's stock price today?

  • The Editas Medicine share price today is $3.38
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing slight buying pressure.

REGN Stock Price Chart

What is Regeneron Pharmaceuticals's stock price today?

  • The Regeneron Pharmaceuticals share price today is $1,012.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing slight selling pressure.

EDIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 39.94 Sell
Chaikin Money Flow: 457652 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.38 - 3.82) Sell
Bollinger Bands (100): (3.8 - 5.48) Sell

REGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -33.17 Sell
Relative Strength Index (14 RSI): 26.47 Sell
Chaikin Money Flow: -309530 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1051.19 - 1165.49) Sell
Bollinger Bands (100): (1009.08 - 1144.08) Sell

EDIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.36 Buy
20-day SMA: 3.6 Sell
50-day SMA: 3.96 Sell
200-day SMA: 6.19 Sell
8-day EMA: 3.38 Buy
20-day EMA: 3.55 Sell
50-day EMA: 3.96 Sell
200-day EMA: 5.77 Sell

REGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1034.95 Sell
20-day SMA: 1094.59 Sell
50-day SMA: 1123.52 Sell
200-day SMA: 1006.39 Buy
8-day EMA: 1041.21 Sell
20-day EMA: 1079.68 Sell
50-day EMA: 1098.8 Sell
200-day EMA: 1012.89 Sell

Editas Medicine Earnings Growth & EDIT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.66 per share, and an increase next year of $0.19 per share.

Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.60 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.56 per share, and an increase next year of $3.57 per share.

Editas Medicine Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Regeneron Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):